000 02474cam  2200361zi 4500
0019.868074
003CaOODSP
00520230906144026
006m     o  d f      
007cr cn|||||||||
008190207s2019    onc     o    f000 0 eng d
020 |a9780660295244
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-249/2019E-PDF
24500|aReporting adverse events following immunization (AEFI) in Canada : |buser guide to completion and submission of the AEFI reports.
24630|aUser guide to completion and submission of the AEFI reports
24617|aUser guide : |bAEFI report form
264 1|aOttawa, Ontario : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c[2019]
300 |a1 online resource (29 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Déclaration de manifestations cliniques inhabituelles (MCI) à la suite d'une immunisation au Canada : guide de l'utilisateur pour remplir et soumettre les rapports de déclaration de MCI.
500 |aCover title.
500 |a"This guide was developed by the Vaccine Vigilance Working Group and the Public Health Agency of Canada."
520 |a"This guide is intended to be used when completing the Report of AEFI for submission to provincial and territorial authorities as well as to PHAC. Its purpose is to provide assistance on how to accurately complete the form. It is not intended to guide treatment. Treatment of all AEFIs should proceed, as appropriate, prior to completing the AEFI form. Following the immediate care of the vaccine recipient, the AEFI form can be completed with all available information. Given the variation in practice between each of the provinces and territories, sections of the form may not be applicable to all settings. If in doubt, please contact your local public health unit"--Guidelines, page 7.
69207|2gccst|aImmunization
69207|2gccst|aHandbooks
7102 |aPublic Health Agency of Canada.
77508|tDéclaration de manifestations cliniques inhabituelles (MCI) à la suite d'une immunisation au Canada : |w(CaOODSP)9.868076
794 |tReporting adverse events following immunization (AEFI) in Canada : |b2022|w(CaOODSP)9.911403
85640|qPDF|s432 KB|uhttps://publications.gc.ca/collections/collection_2019/aspc-phac/HP40-249-2019-eng.pdf